Novartis considers its options for Alcon division

26 January 2017 - Deborah Wilkes

Archived

Novartis is considering "all options" for its Alcon eyecare division, ranging from retaining the business to exiting the business.

Click tags below for more information on topics:

Alcon

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: